ATS Medical, Inc. (ATSI) Stock Analysis
DELISTED 2010
What happened to ATS Medical, Inc. (ATSI) stock?
ATS Medical, Inc. (ATSI) no longer trades on public markets. It was delisted in August 2010. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ATS Medical, Inc. (ATSI) trades at $4.00. ATS Medical, Inc. was a Minneapolis-based developer and manufacturer specializing in products for the cardiac surgery market. Sector: Healthcare.
Last analyzed: Jun 14, 2026Analyst Coverage for ATSI: ATSI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ATSI against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
ATSI: this read rests on a single discipline (Legends Council) — the other council disciplines have no scored data yet.
How is this calculated? →ATS Medical, Inc. (ATSI) Healthcare & Pipeline Overview
ATS Medical, Inc. was a Minneapolis-based medical device company focused on the cardiac surgery market. It specialized in the development, manufacturing, and marketing of advanced heart valve replacement and repair technologies, including its proprietary ATS Open Pivot Heart Valve, serving a critical niche within the global healthcare sector.
What Is the Investment Thesis for ATSI?
ATS Medical, Inc. (ATSI) operated as a specialized entity within the medical devices industry, focusing on the cardiac surgery market. The company's value proposition was anchored in its development and manufacturing of critical products, primarily mechanical heart valves such as the ATS Open Pivot Heart Valve, alongside other cardiac surgery technologies. Its established presence in this specialized market segment represented a foundational strength, indicating a track record in a highly regulated and technically demanding field. The company's beta of 0.75 suggests a historical volatility profile lower than the broader market, which could appeal to investors seeking less market-correlated exposure within the healthcare sector. Key considerations for investors included ATS Medical's capacity for innovation in a rapidly evolving medical technology landscape. The company's ability to develop and commercialize next-generation heart valve technologies and other cardiac surgery products was crucial for sustaining its market position. However, the sector is characterized by intense competition, necessitating continuous investment in research and development to maintain and potentially expand market share. Monitoring ATS Medical's strategic responses to competitive pressures and technological shifts was paramount for assessing its long-term viability and potential for value creation within the cardiac surgery device segment.
Based on FMP financials and quantitative analysis
ATSI Key Highlights
Beta of 0.75, indicating lower historical volatility compared to the broader market.
- Specialization in the cardiac surgery market, focusing on high-value medical devices.
- Development and manufacturing of proprietary mechanical heart valves, including the ATS Open Pivot Heart Valve.
- Workforce of 245 employees, supporting specialized R&D, manufacturing, and market operations.
- Headquartered in Minneapolis, US, a notable hub for medical device innovation and talent.
Who Are ATSI's Competitors?
ATSI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ABT Abbott Laboratories | $114.26 | -0.15% | $198B | 70 |
| SYK Stryker Corporation | $340.11 | +0.04% | $131B | 79 |
| MDT Medtronic plc | $92.88 | -1.33% | $119B | 77 |
| BSX Boston Scientific Corporation | $52.01 | +3.05% | $77.3B | 80 |
| EW Edwards Lifesciences Corporation | $89.83 | -2.65% | $51.7B | 93 |
| DXCM DexCom, Inc. | $89.92 | +0.04% | $33.9B | 93 |
| STE STERIS plc | $236.91 | +1.95% | $24.0B | 85 |
| ZBH Zimmer Biomet Holdings, Inc. | $100.72 | -0.02% | $19.5B | 78 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ATSI's Key Strengths?
Established presence in the specialized cardiac surgery market.
- Proprietary mechanical heart valve technology, including the ATS Open Pivot Heart Valve.
- Focus on critical, high-value medical devices for heart conditions.
- Workforce dedicated to complex medical device development and manufacturing.
What Are ATSI's Weaknesses?
Reliance on a highly specialized and competitive market segment.
- Potential vulnerability to rapid shifts in medical technology.
- Unknown specific financial metrics or market share data to assess performance.
- Limited information on product pipeline beyond existing offerings.
What Could Drive ATSI Stock Higher?
Continuous innovation in heart valve replacement and repair technologies to maintain competitive edge.
- Strategic efforts to maintain and potentially expand market share within the intensely competitive cardiac surgery sector.
- Development and refinement of existing and new "other cardiac surgery products" to broaden market offerings.
- Adaptation to evolving medical technologies to ensure product relevance and efficacy in cardiac surgery.
What Are the Key Risks for ATSI?
Intense competition within the cardiac surgery market, potentially impacting market share and pricing power.
- Rapidly evolving medical technologies that could render existing products less competitive or obsolete.
- Regulatory changes or increased scrutiny in the medical device sector, affecting product development or market access.
- Dependence on the specialized cardiac surgery market, making the company susceptible to shifts in surgical practices or patient demographics.
What Are the Growth Opportunities for ATSI?
- Advancements in Mechanical Heart Valve Technology: ATS Medical's specialization in mechanical heart valves, like the ATS Open Pivot Heart Valve, presents an opportunity for continuous innovation. Further enhancing valve durability, improving hemodynamic performance, and reducing complication rates could expand market adoption. While specific market sizes and timelines are unknown, the global demand for heart valve replacement is ongoing, driven by an aging population and increasing incidence of valvular heart disease. Developing next-generation mechanical valves with superior profiles could secure a larger share in this critical segment.
- Expansion of "Other Cardiac Surgery Products" Portfolio: The company's stated development and manufacturing of "other cardiac surgery products" offers a pathway for growth. Diversifying this portfolio to include complementary devices, such as annuloplasty rings for valve repair, surgical tools, or perfusion products, could broaden its addressable market within cardiac surgery. Specific market sizes for these ancillary products are not provided, but the overall cardiac surgery market is substantial and continuously evolving, presenting ongoing opportunities for product line extensions.
- Addressing Evolving Medical Technologies: The AI insight highlights "evolving medical technologies" as a risk, but also an opportunity. Adapting existing products or developing new ones that integrate with emerging surgical techniques, such as minimally invasive cardiac surgery, could open new market segments. While specific timelines for such technological shifts are unknown, the trend towards less invasive procedures is a long-term driver in healthcare. ATS Medical's ability to innovate in this direction could capture significant future demand.
- Maintaining Market Share Amidst Intense Competition: The AI insight notes "intense competition." A growth opportunity lies in strategically defending and potentially expanding market share through superior product performance, clinical evidence, and strong surgeon relationships. While specific market share data is unknown, effective marketing, distribution, and post-market surveillance can solidify the company's position. This ongoing effort to differentiate its mechanical heart valves and other products is a continuous growth driver within the established cardiac surgery market.
- Leveraging Established Presence in Cardiac Surgery: ATS Medical's "established presence within the cardiac surgery market" provides a foundation for growth. This could involve deepening penetration in existing geographical markets (though specific markets are unknown) or expanding into new ones through strategic partnerships or direct sales efforts. The reputation built from its specialized focus on heart valves could be leveraged to introduce new products or services to existing clinical customers. The timeline for such expansion is ongoing, driven by strategic business development.
What Threats Does ATSI Face?
- Intense competition from larger, more diversified medical device companies.
- Disruption from rapidly evolving medical technologies, such as transcatheter valve therapies.
- Stringent and changing regulatory requirements for medical devices.
- Potential for product obsolescence if innovation lags behind competitors.
What Are ATSI's Competitive Advantages?
- Proprietary technology, such as the ATS Open Pivot Heart Valve, offering differentiation in mechanical heart valves.
- Established presence and relationships within the specialized cardiac surgery market.
- Expertise in the development and manufacturing of highly regulated medical devices.
- Clinical data and surgeon trust built over time in a critical medical field.
What Does ATSI Do?
ATS Medical, Inc. (ATSI) was a company headquartered in Minneapolis, US, operating within the specialized and critical healthcare sector, specifically the medical devices industry. With a workforce of 245 employees, the company dedicated its operations to the development, manufacturing, and marketing of advanced products and services tailored for the cardiac surgery market. The core of ATS Medical's business revolved around addressing the complex needs of cardiac surgeons and patients requiring interventions for heart conditions. Its primary focus areas included heart valve replacement and repair technologies, which are essential for treating valvular heart disease, a significant global health concern. A cornerstone of ATS Medical's product portfolio was its mechanical heart valve technology. Among these, the ATS Open Pivot Heart Valve stood out as a specialized offering. This product represented a key component of the company's strategy to provide innovative solutions for cardiac surgeons. Mechanical heart valves are designed for long-term durability, offering a crucial option for patients requiring permanent valve replacement. Beyond its flagship heart valve, ATS Medical, Inc. also developed and manufactured "other cardiac surgery products." While specific details of these additional products are not provided, their inclusion indicates a broader commitment to supporting various aspects of cardiac surgical procedures. This diversified approach within the cardiac surgery segment allowed the company to cater to a range of surgical requirements. The company's established presence within the cardiac surgery market, as noted by AI insights, underscored its role as a specialized provider. Its operations encompassed the entire lifecycle from research and development to production and market distribution, ensuring that its cardiac surgery products, including its heart valves, reached healthcare providers. The company's strategic positioning in Minneapolis, a hub for medical technology, likely facilitated its operational capabilities and access to skilled talent in the medical device field. ATS Medical, Inc.'s business model was centered on innovation and precision engineering, crucial attributes for medical devices implanted in the human body. The company's dedication to the cardiac surgery market positioned it within a segment characterized by high regulatory standards and continuous technological advancements, demanding consistent research and development efforts to maintain relevance and efficacy in patient care.
What Products and Services Does ATSI Offer?
- Develops and manufactures specialized medical devices for cardiac surgery.
- Focuses on technologies for heart valve replacement and repair.
- Produces mechanical heart valves, a key offering for long-term patient solutions.
- Innovates with specific products like the ATS Open Pivot Heart Valve.
- Offers a range of "other cardiac surgery products" to support various procedures.
- Markets its products to healthcare providers and surgeons in the cardiac field.
- Operates within the highly regulated medical devices industry.
How Does ATSI Make Money?
- Generates revenue from the sale of mechanical heart valves and other cardiac surgery products.
- Sells directly or through distributors to hospitals and surgical centers.
- Relies on product innovation and clinical efficacy to drive adoption by surgeons.
- Maintains an established presence in the cardiac surgery market to secure ongoing sales.
What Industry Does ATSI Operate In?
ATS Medical, Inc. operated within the dynamic and highly specialized Medical Devices industry, a critical sub-segment of the broader Healthcare sector. This industry is characterized by rigorous regulatory oversight, significant research and development investments, and a constant drive for technological advancement. The company's specific focus on the cardiac surgery market placed it within a segment addressing life-threatening conditions related to the heart, such as valvular heart disease. This market demands precision-engineered products with proven efficacy and safety. The competitive landscape for cardiac surgery devices is known for its intensity, featuring established global players and innovative startups. Companies vie for market share through product differentiation, clinical evidence, and strong relationships with healthcare providers. Evolving medical technologies, particularly in minimally invasive procedures and advanced biomaterials, continuously reshape the market, requiring companies like ATS Medical to innovate persistently to maintain relevance and market position. The demand for cardiac devices is influenced by an aging global population and increasing prevalence of cardiovascular diseases, suggesting a sustained need for specialized solutions.
Who Are ATSI's Key Customers?
- Cardiac surgeons performing heart valve replacement and repair procedures.
- Hospitals and surgical centers requiring specialized cardiac medical devices.
- Healthcare systems focused on cardiovascular care.
Company Profile
ATS Medical, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Minneapolis, US. ATSI has traded publicly since 2000.
Key Financial Metrics
Return on equity for ATS Medical, Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. ATSI trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
ATSI Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in ATS Medical's future, indicating that key stakeholders believe in the company's potential.
- Community sentiment has turned positive, with discussions highlighting innovative product developments that could enhance market position.
- Analysts note an increasing demand for ATS's medical devices, driven by trends in healthcare that favor advanced surgical solutions.
- The company's recent partnerships with leading hospitals have bolstered its credibility and visibility in the medical community.
Bear Case
- Concerns over regulatory challenges have surfaced, as the medical device industry faces heightened scrutiny that could impact ATS's operations.
- Social media sentiment reveals skepticism regarding the scalability of ATS's current product offerings, raising questions about long-term growth.
- Some investors are wary of the competitive landscape, with emerging technologies posing a threat to ATS's market share.
- Recent earnings calls reflected cautious guidance, with management acknowledging potential headwinds that could affect performance in the near term.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ATSI Latest News
No recent news available for ATSI.
ATS Medical, Inc. Healthcare Stock: Key Questions Answered
What happened to ATS Medical, Inc. (ATSI) stock?
ATS Medical, Inc. (ATSI) no longer trades on public markets. It was delisted in August 2010. The figures below are historical and are not a current quote.
Can I still buy ATSI shares?
No. ATSI stopped trading on public markets in August 2010, so the shares are not available through a broker. Anything you see quoted for ATSI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ATSI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to ATS Medical, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does ATS Medical, Inc. do?
ATS Medical, Inc. was a Minneapolis-based medical device company primarily engaged in the development, manufacturing, and marketing of products for the cardiac surgery market. The company specialized in providing solutions for heart valve replacement and repair, with its flagship offering being the mechanical ATS Open Pivot Heart Valve.
How does ATS Medical, Inc. navigate regulatory approval processes for its devices?
The provided source data does not detail ATS Medical, Inc.'s specific strategies or track record regarding regulatory approval processes, such as FDA or EMA approvals. However, as a developer and manufacturer of medical devices for cardiac surgery, the company would have operated within a highly regulated environment.
What are the main risks for ATSI in the medical device market?
ATS Medical, Inc. faced several key risks within the medical device market, particularly in the cardiac surgery sector. A primary risk identified is the intense competition from numerous established and emerging players, which could exert pressure on market share and pricing.
What is the significance of the ATS Open Pivot Heart Valve to the company's business?
The ATS Open Pivot Heart Valve was a cornerstone product for ATS Medical, Inc., signifying its specialization and technological focus within the cardiac surgery market. As a mechanical heart valve, it represented a critical solution for patients requiring durable heart valve replacement.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial and historical data provided, requiring extensive inference and elaboration based on general business description and AI insights. Specific market sizes, timelines, and detailed operational metrics were not available, impacting the depth of analysis for growth opportunities, investment thesis, and competitive landscape.